Invention Grant
- Patent Title: Baculovirus-based production of biopharmaceuticals free of contaminating baculoviral virions
-
Application No.: US16551787Application Date: 2019-08-27
-
Publication No.: US11236307B2Publication Date: 2022-02-01
- Inventor: Otto-Wilhelm Merten , Martin Marek , Monique Van Oers
- Applicant: GENETHON
- Applicant Address: FR Evry
- Assignee: GENETHON
- Current Assignee: GENETHON
- Current Assignee Address: FR Evry
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: EP09305761 20090817
- Main IPC: C12N7/00
- IPC: C12N7/00 ; C12N15/86
Abstract:
The present invention relates to methods for the production of biopharmaceuticals implementing a baculovirus-based system. These methods advantageously allow the production of biopharmaceuticals with a reduced number of or without contaminating baculoviral virions.
Public/Granted literature
- US20200002683A1 BACULOVIRUS-BASED PRODUCTION OF BIOPHARMACEUTICALS FREE OF CONTAMINATING BACULOVIRAL VIRIONS Public/Granted day:2020-01-02
Information query
